Skip to main content

5 February 2026

Last updated: Thursday 5 February 2026

User account anon menu

Login
Register and subscribe

Search

Home
News
About MedNous
Research Directory
Contact Us
- Contact Form

Menu

Breadcrumb

Home
Research Directory

Research Directory

A greater patient voice in drug development

Sunday 26 October 2014

Interviewee/Contributor

Richard Pops

Organisation

Alkermes Plc

Alkermes pioneers trial design in depression

Monday 17 February 2014

Interviewee/Contributor

Richard Pops

Organisation

Alkermes Plc

Organisations

TiGenix NV
Polyplus-Transfection SA
MedNous editorial board member
ALK-Abelló A/S
Aravis Venture
CEPI
BC Platforms AG
University of Pennsylvania, Perelman School of Medicine
National Institute for Biological Standards and Control
Cell Therapy Catapult Ltd

Interviewees and Contributers

Gabriel Festoc
Gwen Melincoff
Chris Maggos
Greg Mullen
Ruth March
Jennifer Cubino
Michael Salgaller, Michele Newton and Michael Pollack
Rudy Dekeyser
Simon Lovestone
Philip Vanek

Select a News Category

Clinical Research
Company News
Finance, Grants, Deals
IPR & Legal
Regenerative Medicine
Regulation & Policy
Research & University News

Recent Appointments

German biotech DISCO Pharmaceuticals appoints CEO

Monday 19 January 2026

argenx in CEO transition

Monday 19 January 2026

PureTech Health appoints CEO

Monday 19 January 2026

New CEO at Tacalyx

Monday 19 January 2026

Tubulis appoints oncology expert as CMO

Monday 19 January 2026

View more appointments

Looking for more?

MedNous covers medical news and more. See more in our various site sections.

News
Industry appointments
Events
Research directory
Subscribe

Footer

Privacy policy

© 2026 Evernow Publishing Ltd.

Home
News
- News
- Appointments
- Events
About MedNous
Research Directory
Contact Us
- Contact Form